Sort   by:  
 Page size 
UnknownCombined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.
Not available
S-EPMC2904527 | biostudies-literature
UnknownWarfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.
Not available
S-EPMC2427171 | biostudies-literature
UnknownCarrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
Not available
S-EPMC379096 | biostudies-literature
UnknownMaple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
Not available
S-EPMC1226071 | biostudies-literature
UnknownExperience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
Not available
S-EPMC2970726 | biostudies-literature
UnknownIdentification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.
Not available
S-EPMC3310336 | biostudies-literature
UnknownMulti-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.
Not available
S-EPMC3396745 | biostudies-literature
UnknownCYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
Not available
S-EPMC2737687 | biostudies-literature
UnknownNemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants.
Not available
S-EPMC10620380 | biostudies-literature
UnknownSARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves.
Not available
S-EPMC9322964 | biostudies-literature
Sort   by:  
 Page size